These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 380461)

  • 1. Synergistic effects of ampicillin-aminoglycoside combinations on group B streptococci.
    Cooper MD; Keeney RE; Lyons SF; Cheatle EL
    Antimicrob Agents Chemother; 1979 Mar; 15(3):484-6. PubMed ID: 380461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.
    Watanakunakorn C; Glotzbecker C
    J Med Microbiol; 1977 Feb; 10(1):133-8. PubMed ID: 584243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-killing kinetics of group B streptococci.
    Schauf V; Deveikis A; Riff L; Serota A
    J Pediatr; 1976 Aug; 89(2):194-8. PubMed ID: 781200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of apalcillin alone and in combination with four aminoglycoside antibiotics against Pseudomonas aeruginosa.
    Höffler U
    Chemotherapy; 1986; 32(3):255-9. PubMed ID: 3086049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci.
    Swingle HM; Bucciarelli RL; Ayoub EM
    J Infect Dis; 1985 Sep; 152(3):515-20. PubMed ID: 3897398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of Streptococcus faecalis isolates with high-level resistance to multiple aminocyclitol aminoglycosides.
    Ikeda DP; Barry AL; Andersen SG
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3):171-7. PubMed ID: 6430629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of amoxycillin against enterococci and synergism with aminoglycoside antibiotics.
    Russell EJ; Sutherland R
    J Med Microbiol; 1975 Feb; 8(1):1-10. PubMed ID: 1039329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of aminoglycoside-penicillin synergy against Enterococcus faecium using high-content aminoglycoside disks.
    Torres C; Tenorio C; Lantero M; Zarazaga M; Baquero F
    Eur J Clin Microbiol Infect Dis; 1995 Oct; 14(10):878-82. PubMed ID: 8605901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimum choice of antibiotic treatment in neonatal infections due to group B streptococci].
    Bingen E; Lambert-Zechovsky N; Guihaire E; Mancy C; Aujard Y; Mathieu H
    Pathol Biol (Paris); 1986 May; 34(5):530-3. PubMed ID: 3534738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal studies of penicillin-gentamicin combinations against group B streptococci.
    Overturf GD; Horowitz M; Wilkins J; Leedom J; Steinberg E
    J Antibiot (Tokyo); 1977 Jun; 30(6):513-8. PubMed ID: 328471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility of streptococcal strains associated with infective endocarditis.
    Etienne J; Gruer LD; Fleurette J
    Eur Heart J; 1984 Oct; 5 Suppl C():33-7. PubMed ID: 6394332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefotaxime aminoglycoside interactions.
    Pierce MA; Elliott AM; Cobbs CG
    Chemotherapy; 1985; 31(5):336-45. PubMed ID: 4053733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ampicillin-amikacin and ampicillin-rifampin on enterococci.
    Iannini PB; Ehret J; Eickhoff TC
    Antimicrob Agents Chemother; 1976 Mar; 9(3):448-51. PubMed ID: 1045914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis.
    Sahm DF; Torres C
    J Clin Microbiol; 1988 Feb; 26(2):257-60. PubMed ID: 3125218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of cefotaxime and aminoglycosides against enterococci in vitro.
    Elliott AM; Karam GH; Cobbs CG
    Antimicrob Agents Chemother; 1983 Dec; 24(6):847-50. PubMed ID: 6318661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoglycoside-resistant enterococci.
    Basker MJ; Slocombe B; Sutherland R
    J Clin Pathol; 1977 Apr; 30(4):375-80. PubMed ID: 404337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.
    Yadav R; Bulitta JB; Schneider EK; Shin BS; Velkov T; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
    Murray PR
    Antimicrob Agents Chemother; 1980 Mar; 17(3):474-6. PubMed ID: 6252830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.
    Yadav R; Bulitta JB; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.